NXTC · NextCure, Inc.
AI read · Bad for NXTC
The AI's read
That shortfall puts NextCure's continued Nasdaq listing at risk if the merger does not close or another plan fails. The merger is expected before the deadline and could restore compliance, but it still needs stockholder approval and other closing conditions.